Literature DB >> 26137076

High performance liquid chromatography: Tandem mass spectrometric determination of cisplatin levels in different visceral pleura layers of rats.

Hui Xia1, Wen Zhang1, Yingjie Li1, Changhai Yu1.   

Abstract

The aim of the present study was to investigate the concentration of cisplatin in different layers of the visceral pleura in rats, following drug administration. In this study, a sensitive and specific liquid chromatography method coupled with electrospray ionization-tandem mass spectrometry was established to investigate the disposition of cisplatin in different layers of the visceral pleura in rats. Methodological data, including specificity, linearity, accuracy, recovery, precision and lower limits of quantification, confirmed that this novel method may be used to efficiently quantify the cisplatin concentrations in visceral pleura of rats following administration of the drug. Furthermore, the results demonstrated that the desired drug concentration was not achieved in the outer or inner elastic layers of the visceral pleura following injection with cisplatin through various administration methods.

Entities:  

Keywords:  cisplatin; disposition; liquid chromatography/electrospray ionization-tandem mass spectrometry; visceral pleura layer

Year:  2015        PMID: 26137076      PMCID: PMC4467358          DOI: 10.3892/ol.2015.2989

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  28 in total

1.  T-stage of non-small cell lung cancer directly invading an adjacent lobe.

Authors:  Seok Jin Haam; In Kyu Park; Hyo Chae Paik; Dae Joon Kim; Doo Yun Lee; Jin Gu Lee; Mi Kyung Bae; Kyung Young Chung
Journal:  Eur J Cardiothorac Surg       Date:  2012-06-21       Impact factor: 4.191

2.  Direct injection of lipophilic compounds in the organic phase from liquid-liquid extracted plasma samples onto a reversed-phase column.

Authors:  Henrik Nordberg; Gunilla Jerndal; Richard A Thompson
Journal:  Bioanalysis       Date:  2011-09       Impact factor: 2.681

Review 3.  Adjuvant therapy in non-small cell lung cancer: current and future directions.

Authors:  Randeep Sangha; Julie Price; Charles A Butts
Journal:  Oncologist       Date:  2010-08-03

4.  Simultaneous quantitative analysis of bioactive sphingolipids by high-performance liquid chromatography-tandem mass spectrometry.

Authors:  Jacek Bielawski; Zdzislaw M Szulc; Yusuf A Hannun; Alicja Bielawska
Journal:  Methods       Date:  2006-06       Impact factor: 3.608

5.  Visceral pleural invasion is not a significant prognostic factor in patients with a part-solid lung cancer.

Authors:  Aritoshi Hattori; Kenji Suzuki; Takeshi Matsunaga; Kazuya Takamochi; Shiaki Oh
Journal:  Ann Thorac Surg       Date:  2014-06-21       Impact factor: 4.330

6.  Enhancement of lexatumumab-induced apoptosis in human solid cancer cells by Cisplatin in caspase-dependent manner.

Authors:  Xiu-Xian Wu; Yoshiyuki Kakehi
Journal:  Clin Cancer Res       Date:  2009-03-10       Impact factor: 12.531

Review 7.  Ultra high performance liquid chromatography tandem mass spectrometry determination and profiling of prohibited steroids in human biological matrices. A review.

Authors:  Fabio Gosetti; Eleonora Mazzucco; Maria Carla Gennaro; Emilio Marengo
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2012-12-20       Impact factor: 3.205

Review 8.  Cisplatin versus carboplatin in NSCLC: is there one "best" answer?

Authors:  Rachel E Sanborn
Journal:  Curr Treat Options Oncol       Date:  2009-02-19

Review 9.  Mass spectrometry techniques in the survey of steroid metabolites as potential disease biomarkers: a review.

Authors:  Maria João Gouveia; Paul J Brindley; Lúcio Lara Santos; José Manuel Correia da Costa; Paula Gomes; Nuno Vale
Journal:  Metabolism       Date:  2013-05-07       Impact factor: 8.694

Review 10.  The seventh tumour-node-metastasis staging system for lung cancer: Sequel or prequel?

Authors:  Jan P van Meerbeeck; Annelies Janssens
Journal:  EJC Suppl       Date:  2013-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.